top of page
close-up-scientist-analyzing-lab-vacutainer-with-fluid.jpg

RESEARCH, TECHNOLOGY, AND COLLABORATION TO STRENGTHEN GENE THERAPY IN BRAZIL.

INTERGEN (National Institute of Science and Technology in Gene Therapy) brings together research groups from different regions of the country in a network dedicated to advancing gene therapy in Brazil.

As part of the National Institutes of Science and Technology (INCTs) program, INTERGEN connects researchers, institutions, and diverse expertise to promote scientific research, technological development, innovation, and human resource training.

OUR PURPOSE

STRENGTHENING BRAZILIAN CAPACITY IN GENE THERAPY

INTERGEN connects existing expertise in the country to expand scientific collaboration and strengthen the national capacity to research, develop technologies, and train professionals specializing in gene therapy.

SCIENTIFIC RESEARCH

To advance knowledge in different areas of gene therapy.

TECHNOLOGICAL DEVELOPMENT

Strengthen the national capacity to develop technologies and new approaches.

TRAINING

To contribute to the training of researchers and specialized professionals.

COLLABORATION

Bringing groups, institutions, and different areas of knowledge closer together.

INNOVATION

To stimulate scientific and technological development in Brazil.

RESEARCH TEAM

Meet the researchers who are part of INTERGEN and learn more about their areas of expertise, research, and contributions to gene therapy in Brazil.

opt_bryan.jpg

Bryan E. Strauss

Laboratório de Vetores Virais -

FMUSP​

Foto do PI - Guilherme Baldo.jpg

Guilherme Baldo

Terapia gênica para doenças raras - UFRGS

9b648a7a-eba1-476a-90b7-a5bc018ce1d5_edited.png

Bruna G. de Carvalho

Escola Politécnica da Universidade de São Paulo (EPUSP)

Foto do PI - Martín Bonamino_edited.jpg

Martín Bonamino

Cellular and gene immunotherapy -

Fiocruz

Photo by PI - Vinicius Ribas.jpg

Vinicius Ribas

Research Group on Gene Therapy and Neurodegeneration - UFMG

Photo of PI - Milena Botelho Pereira Soares_edited.jpg

Milena B. Pereira Soares

Tissue Engineering and Immunopharmacology - Fiocruz

Photo of PI - Antonio Carlos de Freitas.jpg

Antonio Carlos de Freitas

Molecular Studies and Experimental Therapy Group - UFPE

Photo by PI - Marcio Jose Tiera.jpg

Marcio José Tiera

Biomaterials and Nanotechnology - UNESP

Photo by PI - Roberta Stilhano_edited.jpg

Roberta Sessa Stilhano Yamaguchi

Stilhano's Laboratory - FCMSCSP

​​​

Photo by PI - Hilda Petrs Silva_edited.jpg

Hilda Petrs Silva

Laboratory of Gene Therapy and Viral Vectors - UFRJ

 

Photo by PI - Ricardo Weinlich.jpg

Ricardo Weinlich

Proadi Sickle Cell Anemia Group - Albert Einstein Israelite Hospital

 

PHOTOS PROF RICARDO-4 (Intergen)_edited.j

Ricardo Titze de Almeida

Center for Gene Therapy for Neurodevelopmental Conditions - UNB

IMG-20240914-WA0012 (1).jpg

Roselena Silvestri Schuh

Cells, Tissues and Genes Group of the Hospital das Clínicas de Porto Alegre

​

image001.png

Marcio Chaim Bajgelman

Center for Technology in Immunotherapy and Biologicals - National Laboratory of Biosciences (LNBio)

dna-cell_edited.jpg

IMPACT

KNOWLEDGE THAT GENERATES RESULTS.

INTERGEN 's activities translate into scientific production, technological development, and collaboration with different sectors.

169

Artigos

Científicos

03

Eventos

Promovidos

12

Capítulos

de Livros

18

Participações

em Mídias

01

Livro

publicado

05

Patents

​

160

Trabalhos em Congressos

08

Partnerships with the private sector

Gene therapy began to take shape in the second half of the 20th century, following advances in genetics and molecular biology. In 1990, the first clinical trial of gene therapy in humans was conducted in the United States. Since then, new technologies, approaches, and applications have been expanding the possibilities of this field of medicine.

HISTORY OF GENE THERAPY

FROM RESEARCH TO THE FIRST THERAPIES

1990

2000s ​

2010s ​

TODAY

First clinical trial of gene therapy in humans.

New vectors and technological advances are driving the development of the area.

The first gene therapies are beginning to reach the market in different countries.

Gene therapy is a growing field, with research and applications focused on various diseases.

social_media_feed_brazil_flag_world_cup_together_by_hexa.png

Gene therapy in Brazil

Brazil has numerous research groups working on developing knowledge and technologies in gene therapy, but it still faces the challenge of expanding its capacity to transform research into solutions developed within the country.

It is in this context that
INTERGEN operates: connecting researchers, institutions, and expertise to strengthen national research and development in gene therapy.

bottom of page